HomeTWST • NASDAQ
add
Twist Bioscience Corp
Previous close
$38.82
Day range
$36.34 - $39.27
Year range
$27.41 - $60.90
Market cap
2.21B USD
Avg Volume
939.37K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 88.71M | 24.08% |
Operating expense | 77.48M | 2.03% |
Net income | -31.59M | 26.54% |
Net profit margin | -35.61 | 40.80% |
Earnings per share | -0.53 | 29.33% |
EBITDA | -28.26M | 27.17% |
Effective tax rate | -0.31% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 270.83M | -12.96% |
Total assets | 608.58M | -16.95% |
Total liabilities | 152.64M | 6.91% |
Total equity | 455.94M | — |
Shares outstanding | 59.65M | — |
Price to book | 5.07 | — |
Return on assets | -14.16% | — |
Return on capital | -15.80% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -31.59M | 26.54% |
Cash from operations | -21.43M | 6.73% |
Cash from investing | -1.54M | -136.88% |
Cash from financing | 17.94M | 1,318.19% |
Net change in cash | -5.07M | 74.84% |
Free cash flow | -11.25M | -3.00% |
About
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
Founded
2013
Website
Employees
923
